Blood-Based Biomarkers of Early-Onset Breast Cancer (original) (raw)

Biochemical and Molecular Markers in Breast Cancer Patients

Mohammad J Al-Jassani

Annals of Tropical Medicine and Public Health, 2019

View PDFchevron_right

Prognostic Significance of Complete Blood Count in Breast Cancer Patients

Preeti Beniwal

2016

View PDFchevron_right

Breast Cancer Gene Research and Medical Practices

Andrea zur Nieden

View PDFchevron_right

Minimal residual disease in breast cancer: in blood veritas

Giulia Siravegna

Clinical Cancer Research, 2014

View PDFchevron_right

Breast Cancer Diagnosis by Different Machine Learning Methods Using Blood Analysis Data

Akif DURDU

International Journal of Intelligent Systems and Applications in Engineering, 2018

View PDFchevron_right

Toward precision medicine of breast cancer

Jack A Tuszynski

Theoretical Biology and Medical Modelling, 2016

View PDFchevron_right

Assessing breast cancer risk

Kathleen Calzone

Postgraduate Medicine, 2004

View PDFchevron_right

Genomic profile of advanced breast cancer in circulating tumour DNA

Andrew M Wardley

Nature Communications, 2021

View PDFchevron_right

New concepts in breast cancer genomics and genetics

Rodrigo Goncalves

Breast Cancer Research, 2014

View PDFchevron_right

Triple Marker Immunohistochemestry Analysis in Breast Cancer Mexican Patients

Ricardo M Cerda-Flores

…, 2012

View PDFchevron_right

Prognostic Insight to Breast Cancer Markers in Nigeria

Oluwayemi J O S H U A Bamikole

Biomedical Journal of Scientific & Technical Research, 2019

View PDFchevron_right

Gene expression profile in breast cancer comprising predictive markers for metastatic risk

Rachana Santiyanont

Genetics and Molecular Research, 2015

View PDFchevron_right

Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer

Suzana Tulac

Cancer research communications, 2022

View PDFchevron_right

Assessment of Cytokeratin Expression in Carcinoma Breast

Aditi Goyal

Journal of Evolution of Medical and Dental Sciences, 2020

View PDFchevron_right

Risk Factors Leading to High Prevalence of Breast Cancer

Noor Fatima

Journal of Applied Pharmacy, 2013

View PDFchevron_right

Tumor markers: From laboratory to clinical utility

Fred C. G. J. Sweep

Molecular & Cellular Proteomics, 2003

View PDFchevron_right

Clinical and molecular aspects of breast cancer: Targets and therapies

Glauber Leitao

Biomedicine & Pharmacotherapy, 2018

View PDFchevron_right

Male Breast Cancer: Immunohistochemical Subtypes and Clinical Outcome Characterization

Diego Pérez Martín

Oncology, 2012

View PDFchevron_right

Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes

Gabriella Oprea-Ilies

Cancer, 2010

View PDFchevron_right

Breast Cancer from Molecular Point of View: Pathogenesis and Biomarkers

Maliheh Parsa

Breast Cancer - Focusing Tumor Microenvironment, Stem cells and Metastasis, 2011

View PDFchevron_right

Annual report of Medical University of Sofia Breast Cancer Biobank

Mariela Vasileva

View PDFchevron_right

Discovery and validation of breast cancer subtypes

Monica Nicolau

BMC Genomics, 2007

View PDFchevron_right

Association between breast and thyroid cancers

Sheryl Green

Advances in Genomics and Genetics, 2014

View PDFchevron_right

Association of HER2 ECD and t-PSA serum levels for possible breast cancer diagnosis

Chien Chou

Sensing and Bio-Sensing Research, 2014

View PDFchevron_right

Genomic assays in breast cancer: Issues yet to settle?

M. Basade

International Journal of Molecular and Immuno Oncology

View PDFchevron_right

Centered on Breast Cancer

Luz Claudio

Environmental Health Perspectives, 2007

View PDFchevron_right

Current challenges in HER2-positive breast cancer

Cristina Falci

Critical Reviews in Oncology/Hematology, 2016

View PDFchevron_right

[Intraoperative molecular diagnosis in breast cancer]

yasuhiro otomo

Nihon rinsho. Japanese journal of clinical medicine, 2007

View PDFchevron_right

Monitoring of minimal residual cancer in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy

Steinar Lundgren

Breast Cancer Research, 2005

View PDFchevron_right

Microcomputer Assisted Reporting and Analysis of Sequential Serum Tumor Marker Determinations

Frank Losos

1985

View PDFchevron_right

Experimental versus numerical data for breast cancer progression

Cheryl Jorcyk

Nonlinear Analysis: Real World Applications, 2012

View PDFchevron_right

Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases

M. Ferno

Breast Diseases: A Year Book Quarterly, 2012

View PDFchevron_right

Evidence of Poorer Survival in Pregnancy-Associated Breast Cancer

Beate Danielsen

Obstetrics & Gynecology, 2008

View PDFchevron_right

Reading the prognosis of the individual with breast cancer

Sarah Pinder

European Journal of Cancer, 2007

View PDFchevron_right

“Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

Carsten Rose

European Journal of Cancer, 2004

View PDFchevron_right